Willis Towers Watson (WTW)
(Delayed Data from NSDQ)
$250.95 USD
-5.97 (-2.32%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $250.95 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth B Momentum D VGM
Willis Towers Watson (WTW) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$299.27 | $329.00 | $255.00 | 16.48% |
Price Target
Based on short-term price targets offered by 15 analysts, the average price target for Willis Towers Watson comes to $299.27. The forecasts range from a low of $255.00 to a high of $329.00. The average price target represents an increase of 16.48% from the last closing price of $256.92.
Analyst Price Targets (15)
Broker Rating
Willis Towers Watson currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 17 brokerage firms. The current ABR compares to an ABR of 2.00 a month ago based on 17 recommendations.
Of the 17 recommendations deriving the current ABR, eight are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 47.06% and 11.76% of all recommendations. A month ago, Strong Buy made up 47.06%, while Buy represented 11.76%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 8 | 8 | 8 | 8 | 7 |
Buy | 2 | 2 | 2 | 2 | 2 |
Hold | 6 | 6 | 6 | 6 | 6 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 1 |
ABR | 2.00 | 2.00 | 2.00 | 2.00 | 2.24 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/5/2024 | Keefe Bruyette & Woods | Meyer Shields | Moderate Buy | Moderate Buy |
3/28/2024 | Raymond James | Charles G Peters | Moderate Buy | Moderate Buy |
3/6/2024 | William Blair | Adam Klauber | Hold | Hold |
2/12/2024 | BMO Capital Markets | Michael Zaremski | Strong Sell | Hold |
2/8/2024 | Roth Capital Partners | Harry Fong | Strong Buy | Strong Buy |
2/8/2024 | Truist Securities | Mark D Hughes | Strong Buy | Strong Buy |
2/6/2024 | Piper Sandler | Paul Newsome | Strong Buy | Strong Buy |
1/2/2024 | Robert W. Baird & Co. | Mark S Marcon | Strong Buy | Strong Buy |
1/2/2024 | Dowling & Partners | Joe Oscar Christiana | Not Available | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.00 |
ABR (Last week) | 2.00 |
# of Recs in ABR | 17 |
Average Target Price | $298.73 |
LT Growth Rate | 10.70% |
Industry | Insurance - Brokerage |
Industry Rank by ABR | 36 of 252 |
Current Quarter EPS Est: | 2.34 |